PARAGON PHARMACEUTICALS
Paragon Pharmaceuticals is a private equity and venture capital firm specializing in investing in startups and growth opportunities
PARAGON PHARMACEUTICALS
Industry:
Venture Capital
Founded:
2012-01-01
Address:
Tulare, California, United States
Country:
United States
Website Url:
http://www.paragonpharma.com
Total Employee:
11+
Status:
Active
Contact:
+1 (866) 945-7860
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Amazon Virginia Region Mimecast
Similar Organizations
Greenhaven Partners
Greenhaven Partners is a private equity and venture capital firm specializing in investments in buyouts.
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.paragonpharma.com
- Host name: url1p.tierra.net
- IP address: 72.1.32.168
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Paragon Pharmaceuticals"
Paragon Biosciences: Accelerating Life Science Innovation
Paragon is a global life science leader that creates, builds and funds innovative biology-based companies to treat and cure diseases.See details»
Paragon Pharmaceuticals - Crunchbase Company …
Organization. Paragon Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Home | Paragon Therapeutics
Spyre Therapeutics is the second company to be formed around assets discovered by and licensed from Paragon. Established in 2023, Spyre is advancing a pipeline of product candidates that maximize the efficacy, safety, …See details»
Paragon Biosciences - LinkedIn
Paragon is a global life science leader that creates, builds and funds innovative biology-based companies. We use biology to accelerate scientific breakthroughs to solve some of society's most ...See details»
Paragon Biosciences - Crunchbase Company Profile & Funding
Paragon Biosciences is a global healthcare company committed to accelerating biomedical research. It solves complex challenges by advancing science.See details»
Paragon Biosciences: Contact Details and Business Profile
Paragon is a global life science leader that creates, builds and funds innovative biology-based companies. We use biology to accelerate scientific breakthroughs to solve some of society's …See details»
Paragon Biosciences Announces the Formation of Paragon Health …
Aug 20, 2019 Brian Friedman, a financial industry veteran with over 20 years of experience in health care investment banking and venture capital, will serve as CEO of the newly created …See details»
Paragon spinout Apogee makes debut with $169M - Fierce Biotech
Dec 7, 2022 Paragon Therapeutics has launched its first spinout, dubbed Apogee Therapeutics. The California company already touts a sizable $169 million to advance at least four of …See details»
Leadership – Jeff Aronin - Paragon Biosciences LLC
Jeff Aronin is a bioscience entrepreneur who built and has sold several successful biotech companies. He has earned a record number of novel drug approvals that improve the lives of …See details»
Paragon Therapeutics, Inc. | LinkedIn
Paragon Therapeutics, Inc. is a biotechnology company dedicated to discovering and developing best-in-class biologics for patients with high unmet needs. Our collaborative team of …See details»
Paragon Therapeutics Announces Oruka Therapeutics Has Entered …
Apr 3, 2024 Paragon Therapeutics Logo (PRNewsfoto/Paragon Therapeutics) "Launching Oruka with such strong investor support is a testament to the company's differentiated portfolio, …See details»
Catalent Has Acquired Paragon Bioservices
Paragon has industry leading capabilities and the most extensive expertise in development and manufacturing of adeno-associated virus (AAV) vectors, the predominant delivery vehicles for …See details»
Investors funnel $275 million into Paragon Therapeutics spinout
Apr 3, 2024 I nvestors have funneled $275 million into a revamped biotech developing new psoriasis and psoriatic arthritis treatments that could be given just once or twice a year.. The …See details»
Paragon Therapeutics Launches First Spinout, Apogee …
Dec 7, 2022 Paragon Therapeutics, Inc. is a biotechnology company leveraging cutting-edge science and technology to identify and propel best-in-class biologics into the clinic for a range …See details»
Catalent Completes Acquisition of Paragon for $1.2 Billion
SOMERSET, N.J. – May 20, 2019 — Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer …See details»
Catalent Completes Acquisition of Paragon Bioservices for $1.2B
SOMERSET, N.J. – May 20, 2019 — Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer …See details»
Immune drug developer Apogee emerges as first spinout of …
Dec 7, 2022 Drug startup Apogee Therapeutics emerged on Wednesday with $169 million in funding to develop new medicines for immunological and inflammatory disorders.. The …See details»
Oruka spins out of Paragon with assets, public listing and cash
Apr 3, 2024 Oruka's preclinical pipeline is an outlier among most companies going public these days as investors crowd around those with human data. That wasn’t of concern to Oruka CEO …See details»
Paragon’s hub-and-spoke biotech model yields another reverse …
Apr 3, 2024 Dive Insight: Once a novelty, “hub-and-spoke” models have gained popularity among producers of biotech startups. Roivant Sciences, BridgeBio Pharma, PureTech Health …See details»
Paragon spinout joins hunt for new type of cancer immunotherapy
Oct 29, 2024 Crescent Biopharma is advancing a drug its CEO claims is “purpose-built” to be a perfected version of Summit Therapeutics’ ivonescimab, which recently beat Merck’s Keytruda …See details»